Method for prognosing osteoporosis phenotypes

Details for Australian Patent Application No. 2007274720 (hide)

Owner Progenika Biopharma S.A.

Inventors Tejedor Hernandez, Diego; Martinez Martinez, Antonio; Simon Buela, Laureano; Cadaval, Ainara

Agent Spruson & Ferguson

Pub. Number AU-A-2007274720

PCT Pub. Number WO2008/010083

Priority 0613843.2 12.07.06 GB; 0623502.2 24.11.06 GB

Filing date 12 July 2007

Wipo publication date 24 January 2008

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

5 March 2009 PCT application entered the National Phase

  PCT publication WO2008/010083 Priority application(s): WO2008/010083

17 September 2009 Assignment before Grant

  Progenika Biopharma S.A. The application has been assigned to Progenika Biopharma S.A.; Bioiberica, S.A.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007274724-Polymorphic forms of an HMG-CoA reductase inhibitor and uses thereof

2007274710-Tartrate salt of (7S)-7-[(5-fluoro-2-methyl-benzyl)oxy]-2 - [(2R)-2-methylpiperazin-1-yl]-6,7-dihydr o-5H-cyclopenta[b]pyridine